Advances in Nanotechnology-Enabled Optical Biosensors for Dengue Virus Detection: A Systematic Review
- PMID: 40734186
- DOI: 10.1002/med.70006
Advances in Nanotechnology-Enabled Optical Biosensors for Dengue Virus Detection: A Systematic Review
Abstract
The dramatic surge in dengue cases in early 2024, endangering half the global population, urgently necessitates faster diagnostic methods. Nanotechnology-enabled optical biosensors offer a promising avenue, leveraging nanomaterial properties for highly sensitive detection of dengue virus (DENV), potentially surpassing conventional techniques in terms of simplicity, speed, and cost-effectiveness. This systematic review analyzes recent advancements in these biosensors for DENV diagnosis. Following PRISMA 2020 guidelines, we systematically searched PubMed, Embase, Scopus, Web of Science, and Cochrane Library databases (2010-June 1, 2025; OSF: https://osf.io/3gmey/). The methodological quality of the 98 included studies was assessed using a modified CASP checklist. Diverse nanotechnology-based optical biosensors were identified. SPR (36.7%) was the most common transducer, followed by fluorescence (24.5%), colorimetry (15.3%), and SERS (8.2%). Gold-based nanomaterials (35.7%) were most frequently employed, with silver nanomaterials (15.3%), quantum dots (15.3%), and graphene-based materials (15.3%) also showing promise. DENV NS1 protein was the primary target analyte (21.4%). Importantly, almost half of the studies (44.9%) used clinically relevant human samples. While many optical biosensors show promise, challenges hinder their demonstration of the true potential for point-of-care use in their current format; however, they offer high specificity and faster results, laying a strong foundation for cost-effective clinical diagnostics. Nanotechnology-driven optical biosensors offer a transformative approach for DENV detection. Advances in computational design and green synthesis of novel nanomaterials are key to addressing stability and field-deployment challenges. These innovations are crucial for developing robust, sensitive, and user-friendly tools to manage dengue and improve patient outcomes globally.
Keywords: dengue virus; diagnostics; nanomaterials; optical biosensor; point‐of‐care.
© 2025 Wiley Periodicals LLC.
References
-
- S. Malik, O. Ahsan, H. Mumtaz, M. Tahir Khan, R. Sah, and Y. Waheed, “Tracing Down the Updates on Dengue Virus‐Molecular Biology, Antivirals, and Vaccine Strategies,” Vaccines 11 (2023): 1328, https://doi.org/10.3390/vaccines11081328.
-
- P. R. Asish, S. Dasgupta, G. Rachel, B. S. Bagepally, and C. P. Girish Kumar, “Global Prevalence of Asymptomatic Dengue Infections—A Systematic Review and Meta‐Analysis,” International Journal of Infectious Diseases 134 (2023): 292–298, https://doi.org/10.1016/j.ijid.2023.07.010.
-
- S. M. Stanley, H. K. Khera, S. Chandrasingh, C. E. George, and R. K. Mishra, “A Comprehensive Review of Dengue With a Focus on Emerging Solutions for Precision and Timely Detection,” International Journal of Biological Macromolecules 254 (2023): 127613, https://doi.org/10.1016/j.ijbiomac.2023.127613.
-
- J. Zeidler, L. Fernandes‐Siqueira, G. Barbosa, and A. Da Poian, “Non‐Canonical Roles of Dengue Virus Non‐Structural Proteins,” Viruses 9 (2017): 42, https://doi.org/10.3390/v9030042.
-
- A. El Sahili and J. Lescar, “Dengue Virus Non‐Structural Protein 5,” Viruses 9 (2017): 91, https://doi.org/10.3390/v9040091.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
